Werkgroep Cardiologische centra Nederland

HARMONY (Completed)

A long term, randomised, double blind, placebo-controlled study to determine the effect of albiglutide, when added to standard blood glucose lowering therapies, on major cardiovascular events in patients with Type 2 diabetes mellitus.
Medicine
albiglutide
Population
Diabetes mellitus
Phase
III
Starting year
2015
More information
ClinicalTrials.gov

Director of Study

drs. P.A.M. Hoogslag (Cardioloog)
Meppel, Isala Diaconessenhuis